Description
About Mesterolone
Mesterolone is an androgen (male hormone) that belongs to the class of ‘anabolic agents’, primarily used to treat low testosterone (natural male hormone or androgen) levels in men with hypogonadism. It is used to treat androgen deficiency and male infertility due to low hormone levels. Mesterolone is indicated for use in male patients only. Hypogonadism, also known as gonad deficiency, is a condition that occurs when the sex glands or gonads (testes in men) produce little or no hormones.
Medicinal Benefits
Mesterolone contains Mesterolone, an anabolic agent. It is an androgen or synthetic steroid hormone and treats androgen deficiency and male infertility due to low hormone levels. Mesterolone helps in replacing low testosterone levels in male patients, thereby maintaining the development and growth of male sex organs. It works by supplementing the natural male hormone. It acts similar to the natural hormone testosterone that maintains proper sexual functions and develops secondary sexual characteristics. Being an anabolic agent, it stimulates the development of mass, strength, and power.
Directions for Use
- Mesterolone can be taken with or without food.
- It is usually taken 3 times daily or as prescribed by your doctor.
- Swallow Mesterolone as a whole with a glass of water.
- Do not crush, chew, or break it.
Storage
Store in a cool and dry place away from sunlight
Side Effects of Mesterolone
- Itching
- Fever
- Rash
- Weight gain
- Hives
- Abdominal pain
- Hot flashes
- Indigestion
- Nausea
- Vomiting
Drug Interactions
Drug Interaction: Mesterolone may interact with fits medicine (phenobarbital, phenytoin), immunosuppressants (cyclosporine), anti-diabetic drugs, hormones (thyroxine), blood thinners, and anaesthetics.
Drug-Food Interaction: No interactions found/established
Drug-Disease Interaction: Mesterolone is contraindicated for use in liver tumours, prostate cancer, male breast cancer, and high blood calcium levels (hypercalcaemia).



















Reviews
There are no reviews yet.